ProMIS Neurosciences Inc

ProMIS Neurosciences Reports 2025 Financial Results & Advances AD, ALS, Parkinson’s Pipeline

ProMIS Neurosciences reports 2025 results and key clinical milestones, spotlighting safe PMN310 and full enrollment of PRECISE‑AD Phase 1b trials.

ProMIS Neurosciences Inc
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

25/03/2026, 13:20

3 minutes to read

ProMIS Neurosciences Inc. Pioneers Hopeful Advances in Neurodegenerative Disease Treatment

ProMIS Neurosciences Inc. is a pioneering biotechnology company working to develop innovative treatments and diagnostics for neurodegenerative diseases such as Alzheimer’s and ALS.

ProMIS Neurosciences Inc
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

14/07/2025, 16:15

3 minutes to read